Skip to main content
Premium Trial:

Request an Annual Quote

LabBook to Provide Browser to Bristol-Myers Squibb

NEW YORK, May 30 – LabBook said Wednesday that it had signed an agreement to provide its XML browser to Bristol-Myers Squibb.

Under the terms of the deal, LabBook will customize its Genomic XML Browser to allow Bristol-Myers Squibb researchers to access, visualize, and annotate information stored in their Accelrys GCG SeqStore database.

"We have chosen BSML [bioinformatics sequence markup language] to standardize our gene discovery data,” Wes Cosand, executive director of bioinformatics at Bristol-Myers Squibb, said in a statement. “This enables us to efficiently integrate our various data sources using LabBook's XML Browser and will help accelerate our efforts to bring drugs to market."

BSML is a publicly available data format that was created by LabBook scientists to represent biological objects in XML.

LabBook of McLean, Va., did not disclose the financial terms of the deal.

Under the terms of the deal Bristol-Myers Squibb will have access to LabBook's OSU Human Genome Database and eLabBook management solution.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.